STOCK TITAN
  1. Home
  2. Sec-filings
  3. HQ
  4. [Form 4] Horizon Quantum Holdings Ltd. Insider Trading Activity

Horizon Quantum (HQ) CSO receives 500,000 options in business combination exchange

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tan Si-Hui reported acquisition or exercise transactions in this Form 4 filing.

Horizon Quantum Holdings Ltd. reported that Chief Science Officer Dr. Tan Si-Hui received a grant of 500,000 stock options on March 19, 2026. Each option is exercisable at $0.15 per Class A Ordinary Share and is exercisable for 2.43499 Class A Ordinary Shares, covering 1,217,494 underlying Class A Ordinary Shares.

These fully vested options were not a new cash purchase but were issued in exchange for Dr. Tan’s 500,000 Legacy Horizon stock options as part of the closing of the Business Combination under the Business Combination Agreement. Following this exchange, Dr. Tan holds 500,000 Company stock options directly.

Positive

  • None.

Negative

  • None.
Insider Tan Si-Hui
Role Chief Science Officer
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 500,000 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 500,000 shares (Direct)
Footnotes (1)
  1. Each stock option is exercisable for 2.43499 Class A Ordinary Shares of Horizon Quantum Holdings Ltd. (the "Company") at a price per share of $0.15. Stock options received as part of the business combination (the "Business Combination") contemplated by the Business Combination Agreement, dated as of September 9, 2025 (the "BCA"), by and among Horizon Quantum Computing Pte. Ltd. ("Legacy Horizon"), dMY Squared Technology Group, Inc., the Company and certain other parties, as described in the Registration Statement on Form F-4, as amended and supplemented (File No. 333-292737), initially filed with the U.S. Securities and Exchange Commission on January 14, 2026, and declared effective on February 17, 2026. Upon the closing of the Business Combination on March 19, 2026, Dr. Tan's stock options exercisable for Legacy Horizon ordinary shares awarded by Legacy Horizon were exchanged for substitute stock option awards of the Company of an equivalent economic value. The stock options held by Dr. Tan are fully vested and exercisable. Pursuant to the BCA and as a result of the closing of the Business Combination, Dr. Tan's 500,000 Legacy Horizon stock options were exchanged for 500,000 stock options of the Company of an equivalent economic value, with an exercise price per Class A Ordinary Share of $0.15.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tan Si-Hui
(Last)(First)(Middle)
C/O HORIZON QUANTUM HOLDINGS LTD.
29 MEDIA CIR. #05-22
(Street)
SINGAPORE138565
(City)(State)(Zip)
SINGAPORE
(Country)		2. Issuer Name and Ticker or Trading Symbol
Horizon Quantum Holdings Ltd. [ HQ ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Science Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$0.15(1)03/19/2026(2)A500,000(1) (3)03/01/2032Class A Ordinary Shares1,217,494(1)(4)500,000D
Explanation of Responses:
1. Each stock option is exercisable for 2.43499 Class A Ordinary Shares of Horizon Quantum Holdings Ltd. (the "Company") at a price per share of $0.15.
2. Stock options received as part of the business combination (the "Business Combination") contemplated by the Business Combination Agreement, dated as of September 9, 2025 (the "BCA"), by and among Horizon Quantum Computing Pte. Ltd. ("Legacy Horizon"), dMY Squared Technology Group, Inc., the Company and certain other parties, as described in the Registration Statement on Form F-4, as amended and supplemented (File No. 333-292737), initially filed with the U.S. Securities and Exchange Commission on January 14, 2026, and declared effective on February 17, 2026. Upon the closing of the Business Combination on March 19, 2026, Dr. Tan's stock options exercisable for Legacy Horizon ordinary shares awarded by Legacy Horizon were exchanged for substitute stock option awards of the Company of an equivalent economic value.
3. The stock options held by Dr. Tan are fully vested and exercisable.
4. Pursuant to the BCA and as a result of the closing of the Business Combination, Dr. Tan's 500,000 Legacy Horizon stock options were exchanged for 500,000 stock options of the Company of an equivalent economic value, with an exercise price per Class A Ordinary Share of $0.15.
/s/ Si-Hui Tan03/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Horizon Quantum (HQ) report for Dr. Tan Si-Hui?

Horizon Quantum reported that Chief Science Officer Dr. Tan Si-Hui received 500,000 stock options on March 19, 2026. These options were issued as an exchange for prior Legacy Horizon options in connection with the closing of the Business Combination.

What are the key terms of Dr. Tan’s new Horizon Quantum (HQ) stock options?

Dr. Tan’s stock options are fully vested, exercisable at $0.15 per Class A Ordinary Share, and expire on March 1, 2032. Each option is exercisable for 2.43499 Class A Ordinary Shares, covering a total of 1,217,494 underlying shares.

How were Dr. Tan’s Legacy Horizon options treated in the Horizon Quantum (HQ) Business Combination?

Upon closing of the Business Combination on March 19, 2026, Dr. Tan’s 500,000 Legacy Horizon stock options were exchanged for 500,000 Horizon Quantum stock options. The company states these substitute options have an equivalent economic value to the original awards.

Is Dr. Tan’s Horizon Quantum (HQ) option grant a new purchase of shares?

The filing describes the transaction as stock options received and exchanged, not an open-market purchase of shares. It is a compensation-related grant and substitution of pre-existing Legacy Horizon options following the Business Combination, with no buy or sell transaction reported.

How many Horizon Quantum (HQ) options does Dr. Tan hold after this transaction?

After the exchange, Dr. Tan holds 500,000 Horizon Quantum stock options directly, as reported in the filing. These options are fully vested and exercisable and relate to 1,217,494 underlying Class A Ordinary Shares at an exercise price of $0.15 per share.